Arquivamento definitivo - Art. 33 da LPI
#11.1.1
11/26/2024
RPI 2812
Application data
Number
112023003873Type
Filing
Publication
PCT
US2021049011 The application was abandoned: examination was not requested within the 36 months following the 09/03/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 11/26/2024. We update with every new RPI gazette, published weekly.
Applicants
TEON THERAPEUTICS, INC.
US
Inventors
D. O. (pessoa física)
US
J. L. (pessoa física)
US
S. K. (pessoa física)
US
IPC Classification
Priority claims
US
63/075,065 · 09/04/2020
Abstract
COCRISTAIS DE UM ANTAGONISTA DO RECEPTOR DE ADENOSINA A2B. Trata-se de cocristais de um antagonista do receptor de adenosina A2B, 3-etil-1-propil-8-(1-(3-(trifluorometil)benzil)-1H-pirazol-4-il)-3,7-di-hidro-1H-purina-2,6-diona, métodos para preparar os cocristais, composições farmacêuticas dos cocristais e usos dos cocristais.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
11/26/2024
RPI 2812
#11.1
09/10/2024
RPI 2801
#1.3
05/23/2023
RPI 2733
#1.1
03/14/2023
RPI 2723
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.